"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

Physicians’ Education Resource (PER ®) is excited to announce the launch of Retina Resource, a comprehensive source of cutting-edge education and information on the latest innovations in anti-VEGF ...

The Association for Research in Vision and Ophthalmology (ARVO) Foundation has announced Maria Vittoria Cicinelli, MD, Denise ...

Goyer amid production restarts and budget adjustments, things are looking up for Apple TV+‘s sci-fi drama Foundation. With the completed third season not yet scheduled but likely to debut this ...

Director of the Inherited Retinal Degeneration Division at the Retina Foundation of the Southwest, Professor of Ophthalmology, Casey Eye Institute, Oregon Health & Science University and a Fellow of ...

Mark Pennesi, M.D., Ph.D., FARVO Director of the Inherited Retinal Degeneration Division at the Retina Foundation of the Southwest, Professor of Ophthalmology, Casey Eye Institute, Oregon Health ...

Director of the Inherited Retinal Degeneration Division at the Retina Foundation of the Southwest, Professor of Ophthalmology, Casey Eye Institute, Oregon Health & Science University and a Fellow ...

The retina is a layered structure that lines the inner surface of the eye. It consists of layers of neurons: light-sensitive photoreceptor cells, bipolar cells, horizontal cells, amacrine cells ...

Like Queen Elizabeth, she loves horses and a great tiara moment. Meghan Markle's refreshed lifestyle brand has a logo with a meaningful symbol. On Feb. 18, the Duchess of Sussex announced that she ...